QC

Quadrature Capital Portfolio holdings

AUM $8.4B
1-Year Est. Return 63.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+63.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.8B
AUM Growth
+$1.34B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,749
New
Increased
Reduced
Closed

Top Buys

1 +$299M
2 +$174M
3 +$152M
4
AMD icon
Advanced Micro Devices
AMD
+$149M
5
TSM icon
TSMC
TSM
+$145M

Top Sells

1 +$282M
2 +$265M
3 +$258M
4
PLTR icon
Palantir
PLTR
+$194M
5
AAPL icon
Apple
AAPL
+$164M

Sector Composition

1 Technology 24.14%
2 Consumer Discretionary 12.45%
3 Industrials 11.48%
4 Financials 10.65%
5 Healthcare 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRDS icon
1401
NerdWallet
NRDS
$529M
-17,343
NU icon
1402
Nu Holdings
NU
$54.8B
-1,389,572
NUVB icon
1403
Nuvation Bio
NUVB
$1.61B
-124,437
NVDA icon
1404
NVIDIA
NVDA
$5.21T
-1,509,988
NVMI
1405
Nova
NVMI
$16.8B
-2,824
OBDC icon
1406
Blue Owl Capital
OBDC
$5.43B
-76,086
OBIO icon
1407
Orchestra BioMed
OBIO
$229M
-15,577
ODFL icon
1408
Old Dominion Freight Line
ODFL
$48.4B
-11,704
OLPX icon
1409
Olaplex Holdings
OLPX
$1.37B
-25,175
OMER icon
1410
Omeros
OMER
$732M
-21,533
ONCY
1411
Oncolytics Biotech
ONCY
$106M
-106,076
ONL
1412
Orion Office REIT
ONL
$165M
-35,400
OPY icon
1413
Oppenheimer Holdings
OPY
$1.01B
-5,940
OSK icon
1414
Oshkosh
OSK
$8.37B
-9,483
OUNZ icon
1415
VanEck Merk Gold Trust
OUNZ
$2.7B
-684,538
OZK icon
1416
Bank OZK
OZK
$5.22B
-4,269
PANW icon
1417
Palo Alto Networks
PANW
$227B
-72,859
PARR icon
1418
Par Pacific Holdings
PARR
$2.95B
-28,793
PBF icon
1419
PBF Energy
PBF
$5.15B
-44,427
PBI icon
1420
Pitney Bowes
PBI
$2.18B
-60,464
PCVX icon
1421
Vaxcyte
PCVX
$6.8B
-25,807
PDBC icon
1422
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.33B
-135,965
PFIS icon
1423
Peoples Financial Services
PFIS
$576M
-5,546
PFLT icon
1424
PennantPark Floating Rate Capital
PFLT
$805M
-43,217
PHAT icon
1425
Phathom Pharmaceuticals
PHAT
$805M
-30,272